Santa Maria Degli Angeli Hospital
- Address
- Via Montereale 24, 33170 Pordenone, Italy
Santa Maria Degli Angeli Hospital - Cardiovascular and Renal Research Center
Santa Maria Degli Angeli Hospital is a distinguished clinical research center specializing in cardiovascular disease and renal disorders. The institution demonstrates particular expertise in conducting advanced therapeutic trials targeting patients with complex cardiorenal conditions, focusing on innovative pharmacological interventions aimed at reducing major cardiovascular events and preserving kidney function.
- Chronic kidney disease (CKD) with hypertension, investigating novel treatments to prevent kidney function decline and cardiovascular mortality
- Heart failure research with reduced ejection fraction, evaluating emerging therapies for symptomatic management
- Atherosclerotic cardiovascular disease (ASCVD) prevention, testing lipid-lowering strategies to reduce heart attacks and strokes
The center's research portfolio emphasizes cardiorenal syndrome and cardiovascular risk reduction, with particular attention to combination therapies and dose-finding studies. Their clinical trials focus on evaluating both efficacy and safety of novel pharmaceutical agents in high-risk patient populations, including those with established vascular disease and compromised kidney function. This comprehensive approach positions the hospital at the forefront of translational medicine in cardiovascular and nephrology care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 31 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB3active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Santa Maria Degli Angeli Hospital
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter Randomized Controlled Trial Comparing Short-Course Amoxicillin/Clavulanic Acid After Fever Resolution to Standard 10-Day Regimen for Febrile Urinary Tract Infections in Children | Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 31 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2025-05-07 | 2025-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.